Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 13,265 | 18,244 | 11,760 | 10,666 | 4,969 |
| Operating Income | -13,265 | -18,244 | -11,760 | -10,666 | -4,969 |
| Interest Expense | 0 | 0 | 2 | -47 | -91 |
| Other Income | 510 | 622 | 660 | 873 | 980 |
| Pre-tax Income | -12,755 | -17,622 | -11,101 | -9,747 | -3,898 |
| Income Tax | N/A | 3 | 2 | 0 | N/A |
| Net Income Continuous | -12,755 | -17,625 | -11,103 | -9,747 | -3,898 |
| Net Income | $-12,755 | $-17,625 | $-11,103 | $-9,747 | $-3,898 |
| EPS Basic Total Ops | -0.32 | -0.44 | -0.28 | -0.25 | -0.10 |
| EPS Basic Continuous Ops | -0.32 | -0.44 | -0.28 | -0.24 | -0.10 |
| EPS Diluted Total Ops | -0.32 | -0.44 | -0.28 | -0.25 | -0.10 |
| EPS Diluted Continuous Ops | -0.32 | -0.44 | -0.28 | -0.24 | -0.10 |
| EPS Diluted Before Non-Recurring Items | -0.32 | -0.44 | -0.28 | -0.24 | -0.22 |
| EBITDA(a) | $-13,086 | $-18,057 | $-11,582 | $-10,491 | $-4,791 |